AsteraSIS Registers 'CoolSonic' with Brazil's ANVISA

AsteraSIS' next-generation high-intensity focused ultrasound (HIFU) medical device, 'CoolSonic', has completed registration with Brazil's ANVISA.

According to AsteraSIS on August 20, through the recent ANVISA registration, the company has secured a foundation for the official distribution and sales of CoolSonic in Brazil. Based on its existing local distribution network and sales experience, AsteraSIS plans to expand product supply and marketing activities in the Brazilian market.

Brazil is one of the major countries in the Latin American aesthetic and medical device market. AsteraSIS intends to actively leverage its accumulated local business experience and distribution channels, gained through previous products, for CoolSonic. In particular, the company aims to strengthen its brand awareness and secure initial references through activities such as product training for local medical professionals, academic marketing, and collaborations with key medical institutions and key opinion leaders.

CoolSonic is a unique HIFU medical device incorporating AsteraSIS's proprietary cooling technology. Its design allows the skin surface to be cooled while delivering focused ultrasound energy to a specific depth below the skin.

Since its launch in Korea, CoolSonic has received positive evaluations from both medical professionals and the market in terms of usability and procedural convenience. With the recent ANVISA registration in Brazil, the company expects to accelerate its overseas market expansion.

A representative from AsteraSIS said, "With this ANVISA registration, we have established a foundation to fully introduce CoolSonic, which has proven its competitiveness in Korea, to the Brazilian market. We will actively use our existing local network and sales experience to ensure CoolSonic settles quickly in the Brazilian market," he added.

This content was produced with the assistance of AI translation services.